JPMorgan Chase & Co’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262K | Sell |
23,218
-379,286
| -94% | -$4.29M | ﹤0.01% | 4344 |
|
|
2025
Q1 | $4.64M | Buy |
402,504
+381,244
| +1,793% | +$4.4M | ﹤0.01% | 2721 |
|
|
2024
Q4 | $180K | Sell |
21,260
-1,350
| -6% | -$11.4K | ﹤0.01% | 4569 |
|
|
2024
Q3 | $262K | Buy |
22,610
+1,670
| +8% | +$19.3K | ﹤0.01% | 4355 |
|
|
2024
Q2 | $247K | Sell |
20,940
-69,620
| -77% | -$820K | ﹤0.01% | 4177 |
|
|
2024
Q1 | $1.07M | Buy |
90,560
+63,768
| +238% | +$756K | ﹤0.01% | 3532 |
|
|
2023
Q4 | $328K | Sell |
26,792
-244,149
| -90% | -$2.99M | ﹤0.01% | 4129 |
|
|
2023
Q3 | $2.61M | Sell |
270,941
-19,334
| -7% | -$186K | ﹤0.01% | 2847 |
|
|
2023
Q2 | $2.61M | Sell |
290,275
-44,034
| -13% | -$396K | ﹤0.01% | 2881 |
|
|
2023
Q1 | $2.63M | Buy |
334,309
+7,306
| +2% | +$57.4K | ﹤0.01% | 2880 |
|
|
2022
Q4 | $2.21M | Buy |
327,003
+190,809
| +140% | +$1.29M | ﹤0.01% | 2895 |
|
|
2022
Q3 | $1.98M | Sell |
136,194
-7,657
| -5% | -$111K | ﹤0.01% | 2917 |
|
|
2022
Q2 | $1.42M | Buy |
143,851
+130,427
| +972% | +$1.28M | ﹤0.01% | 3251 |
|
|
2022
Q1 | $198K | Buy |
13,424
+2,677
| +25% | +$39.5K | ﹤0.01% | 4456 |
|
|
2021
Q4 | $142K | Buy |
10,747
+1,656
| +18% | +$21.9K | ﹤0.01% | 4692 |
|
|
2021
Q3 | $159K | Buy |
9,091
+332
| +4% | +$5.81K | ﹤0.01% | 4516 |
|
|
2021
Q2 | $210K | Buy |
8,759
+425
| +5% | +$10.2K | ﹤0.01% | 4475 |
|
|
2021
Q1 | $214K | Sell |
8,334
-27,239
| -77% | -$699K | ﹤0.01% | 4425 |
|
|
2020
Q4 | $676K | Buy |
35,573
+12,293
| +53% | +$234K | ﹤0.01% | 3590 |
|
|
2020
Q3 | $294K | Sell |
23,280
-7,848
| -25% | -$99.1K | ﹤0.01% | 3587 |
|
|
2020
Q2 | $376K | Sell |
31,128
-28,237
| -48% | -$341K | ﹤0.01% | 3403 |
|
|
2020
Q1 | $454K | Buy |
59,365
+40,223
| +210% | +$308K | ﹤0.01% | 3332 |
|
|
2019
Q4 | $341K | Buy |
19,142
+15,315
| +400% | +$273K | ﹤0.01% | 3602 |
|
|
2019
Q3 | $44K | Sell |
3,827
-33,481
| -90% | -$385K | ﹤0.01% | 4306 |
|
|
2019
Q2 | $806K | Sell |
37,308
-24,754
| -40% | -$535K | ﹤0.01% | 3157 |
|
|
2019
Q1 | $1.78M | Buy |
62,062
+25,267
| +69% | +$723K | ﹤0.01% | 2705 |
|
|
2018
Q4 | $727K | Buy |
36,795
+31,183
| +556% | +$616K | ﹤0.01% | 3199 |
|
|
2018
Q3 | $124K | Sell |
5,612
-1,650
| -23% | -$36.5K | ﹤0.01% | 4039 |
|
|
2018
Q2 | $59K | Sell |
7,262
-13,678
| -65% | -$111K | ﹤0.01% | 4250 |
|
|
2018
Q1 | $199K | Sell |
20,940
-8,133
| -28% | -$77.3K | ﹤0.01% | 3722 |
|
|
2017
Q4 | $283K | Buy |
+29,073
| New | +$283K | ﹤0.01% | 3547 |
|
|
2016
Q1 | – | Sell |
-53
| Closed | -$3K | – | 4215 |
|
|
2015
Q4 | $3K | Buy |
+53
| New | +$3K | ﹤0.01% | 3838 |
|